Table 1.
Cohort Characteristics (n = 295)
| Characteristic | Data |
|---|---|
| Female | 129 (43.8) |
| Median gestational age (IQR) (n = 241), wk | 38 (35.7–39) |
| Premature (<37 wk) (n = 241), % | 33.2 |
| Median birthweight (IQR) (n = 226), kg | 3.18 (2.35–3.7) |
| Race/ethnicity | |
| White | 130 (44.1) |
| Black | 42 (14.2) |
| Hispanic | 4 (1.4) |
| Asian/Pacific Islander | 1 (0.3) |
| Other or unknown | 118 (40.0) |
| Median age at HI diagnosis (IQR) (n = 235), da | 24 (8–161) |
| Median age at diazoxide initiation (IQR) (n = 226), d | 29 (10–142) |
| Median duration of diazoxide exposure (IQR) (n = 137), d | 48 (14–207) |
| Cardiac comorbidity present at diazoxide initiation, n (%) | 35 (11.9) |
| Pulmonary comorbidity present at diazoxide initiation, n (%) | 28 (9.5) |
Unless otherwise noted, values are number (percentage) of patients or median (IQR).
a
Excludes six patients diagnosed with HI within first month of life but missing date of diagnosis.